Aptamer Group (AIM:APTA) has launched a Gates Foundation‑supported research programme with Imperial College London to develop a rapid, field‑compatible test for folic acid in fortified foods.
The work includes an upfront fee to Aptamer to develop sample preparation and extraction methods and to supply its folic acid Optimer® binders to the Güder Research Group, and Aptamer is a developer of next‑generation synthetic binders for the life sciences industry.
"We look forward to collaborating with Imperial College London and the Gates Foundation on this critical initiative and aim to deliver a practical solution that can have a meaningful impact on maternal and child health worldwide," Dr Arron Tolley said.
Folic acid deficiency is a leading preventable cause of birth defects such as Spina Bifida, and many lower‑income countries rely on food fortification but lack rapid point‑of‑production tests for folate.
Aptamer expects to complete its in‑house validation in July, transfer validated Optimer® binders to Imperial, and for Imperial to lead incorporation into lateral flow devices with field validation anticipated by the end of 2026.
The company has proposed a commercial licence fee contingent on successful field validation and anticipates further commercial value from ongoing supply of Optimer® material while retaining full ownership of its IP.
The programme aims to produce an affordable, cold‑chain‑free lateral flow solution that can be used at food processing sites in developing countries.
